Naar www.iknl.nl
- Algemeen > Ileus
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline
----------

Laatst gewijzigd: 2018-10-01, Versie: 3.0, Verantwoording: IKNL, Type: Landelijke richtlijn

Referentielijst

1 - Abu-Rustum NR (1997)
Abu-Rustum NR, Barakat RR, Venkatraman E, et al. Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecol Oncol 1997;64(3):493-5. [link]
 
2 - Akbulut G (2011)

Akbulut G. New perspective for nutritional support of cancer patients: Enteral/parenteral nutrition. Exp. Ther. Med. 2011; 2(4): 675-684. [link]

 
3 - Amelung FJ (2017)
Amelung FJ, Draaisma WA, Consten EC, et al. Self-expandable metal stent placement versus emergency resection for malignant proximal colon obstructions. Surg Endosc. 2017 2017 Apr 13. doi: 10.1007/s00464-017-5512-2. [Epub ahead of print]. [link]
 
4 - Anthony T (2007)
Anthony T, Baron T, Mercadante S, et al. Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage 2007; 34: S49-S59. [link]
 
5 - Aramaki T (2013)

Aramaki T, Arai Y, Inaba Y et al. Transesophageal gastrotubing or malingnant obstruction. JVIR 2013 24: 1011-1017. [link]

 
6 - August DA (1991)

August DA, Thorn D, Fisher RL, Welchek CM. Home parenteral nutrition for patients with inoperable malignant bowel obstruction. J Parenter Enter Nutr 1991;15:323e7. [link]

 
7 - Berger J (2016)
Berger J, Lester P, Rodrigues L. Medical Therapy of Malignant Bowel Obstruction With Octreotide, Dexamethasone, and Metoclopramide. Am J Hosp Palliat Care 2016; 33: 407-10. [link]
 
8 - Bohner H (1998)
Bohner H, Yang Q, Franke C, Verreet PR, Ohmann C. Simple data from history and physical examination help to exclude bowel obstruction and to avoid radiographic studies in patients with acute abdominal pain. Eur J Surg 1998; 164: 777-784. [link]
 
9 - Bozzetti F (2002)

Bozzetti F, Cozzaglio L, Biganzoli E, et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutrition 2002; 21- 281-288. [link]

 
10 - Brard L (2006)

Brard L, Weitzen S, Strubel-Lagan S, et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecol Oncol 2006;103(1):176-80. [link]

 
11 - Brookbanks MA (2002)
Brookbanks MA. Palliative venting gastrosomy in malignant intestinal obstruction. Palliative Medicine 2002; 16: 520-526. [link]
 
12 - Bryan DN (2006)
Bryan DN, Radbod R, Berek JS. An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer. Int J Gynecol Cancer 2006;16(1):125-34. [link]
 
13 - Campagnuta E (1996)
Campagnuta E, Cannizzaro R, Gallo A et al. Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy. Gynecol Oncol 1996; 0197: 103-105. [link]
 
14 - Chakraborty A (2011)

Chakraborty A, Selby D, Gardiner K, et al. Malignant bowel obstruction: natural history of a heterogenous patient population followed prospectively over two years. J Pain Symptom Manage 2011; 41(2): 412-20. [link]

 
15 - Cho YK (2011)
Cho YK, Kim SW, Lee BI, et al. Clinical outcome of self-expandable metal stent placement in the management of malignant proximal colon obstruction. Gut Liver 2011; 5(2):165-70. [link]
 
16 - Chouhan J (2016)
Chouhan J, Gupta R, Ensor J, et al. Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction. Cancer Med 2016; 5(2): 239-47. [link]
 
17 - Clark K (2009)

Clark K, Lam L, Currow D. Reducing gastric secretions, a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction? Support Care Cancer 2009; 17: 1463-1468. [link]

 
18 - Clark K (2009)
Clark K, Lam LT, Gibson S, et al. The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials. Anesthesia 2009; 64: 652-657. [link]
 
19 - Clegg A (2013)
Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet 2013; 381(9868): 752-62. [link]
 
20 - Couhan J (2016)
Couhan J, Gupta R, Ensor J, et al. Retrospective analysis of systemic chemotherapy and Total parenteral nutrition for the treatment of malignant small bowel obstruction. Cancer Med 2016; 5(2): 239-247. [link]
 
21 - Cousins SE (2016)
Cousins SE, Tempest E, Feuer DJ. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastro-intestinal cancer. Cochrane Database Systematic Rev 2016; 1: CD002764. [link]
 
22 - Currow DC (2015)
Currow DC, Quinn S, Agar M, et al. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage 2015; 49: 814-821. [link]
 
23 - Dalal KM (2011)

Dalal KM, Gollub MJ, Miner TJ, et al. Management of patients with malignant bowel obstruction and stage IV colorectal cancer. J Palliat Med. 2011; 14: 822-28. [link]

 
24 - Di Saverio S (2013)
Di Saverio S, Coccolini F, Galati M, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emergency Surg 2013; 8: 42. [link]
 
25 - Dittrich A (2017)

Dittrich A, Schubert B, Kramer M, et al. Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastro-intestinal obstruction. Support Care Cancer 2017; 25: 2849-2856. [link]

 
26 - Dolan EA (2011)
Dolan EA. Malignant bowel obstruction: a review of current treatment strategies. Am J Hospice Palliat Med 2011; 28(8): 576-82. [link]
 
27 - Diver E (2013)

Diver E, O Connor O, Garret L, et al. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecol Oncolog 2013; 129(2): 332-5. [link]

 
28 - Duerksen DR (2004)

Duerksen DR, Ting E, Thomson P, et al. Is there a role for TPV in terminally ill patients with bowel obstruction? Nutrition 2004; 20(9): 760-3. [link]

 
29 - Dunn GP (2016)

Dunn GP. Shared decision-making for the elderly patient with a surgical condition. Br J Surg. 2016; 103(2): e19-20. [link]

 
30 - Dyson JK (2017)
Dyson JK, Thompson N, On half of the Northern Nutrition Network. Adult parenteral nutrition in the North of England: a region-wide audit. BMJ Open 2017; 7(1): eQ 12663. [link]
 
31 - Eskeninen M (1994)
Eskeninen M, Ikonen J, Lipponen P. Contributions of history-taking, physical examination and computer assistance to diagnosis of acute small-bowel obstruction. Scand J Gastroenterol 1994; 29: 715-721. [link]
 
32 - Ferguson HJM (2015)
Ferguson HJM, Ferguson CI, Speakman J, et all T. Management of intestinal obstruction in advanced malignancy. Ann Med Surg 2015; 4: 264-70. [link]
 
33 - Feuer DJ (2000)
Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastro-intestinal cancer. Cochrane Library 2000, Issue 1. Art.No.:CD001219.DOI:10.1002/14651858.CD001219. [link]
 
34 - Fiori E (2004)
Fiori E, Lamazza A, Cesare A, et al. Palliative management of malignant rectosigmoidal obstruction. Colostomy versus. endoscopic stenting. A randomized prospective trial. Anticancer Res 2004: 265-8. [link]
 
35 - Fiori E (2012)

Fiori E, Lamazza A, Schillaci A, et al. Palliative management for patients with subacute obstruction and stage IV unresectable rectosigmoid cancer: Colostomy versus endoscopic stenting: Final results of a prospective randomized trial. Am J Surgery 2012; 204: 321-26. [link]

 
36 - Fried TR (2011)
Fried TR, Tinetti ME, Iannone L, et al. Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med 2011; 171(20): 1854-6. [link]
 
37 - Gans SL (2014)
Gans SL, Stoker J, Boermeester MA. Een buikoverzichtsfoto voor het gevoel van de dokter. Ned Tijdschr Geneesk 2014; 158: A493.
 
38 - Gill TM (2015)
Gill TM, Gahbauer EA, Han L,et al. The role of intervening hospital admissions on trajectories of disability in the last year of life: prospective cohort study of older people. BMJ 2015; 350: h2361. [link]
 
39 - Handforth C (2015)

Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol 2015; 26(6): 1091-101. [link]

 
40 - Henry JC (2012)
Henry JC, Pouly S, Sullivan R, et al. A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery 2012; 152: 747-757. [link]
 
41 - Hooft van JE (2008)
Hooft van JE, Fockens P, Marinelli AW, et al. Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 2008; 40: 184-91. 10.1055/s-2007-995426. [link]
 
42 - Hooft van JE (2014)
Hooft van JE, Van Halsema EE, Vanbiervliet G et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastro-intestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2014; 46(11): 990-1053. [link]
 
43 - Huhmann MB. (2012)

Huhmann MB., August DA. Perioperative nutritional support in cancer patients. Nutr Clin Pract 2012; 27:586-592. [link]

 
44 - IKNL

IKNL, Integraal Kankercentrum Nederland. Richtlijn Ondervoeding bij patienten met kanker. http://www.oncoline.nl/ondervoeding-bij-patienten-met-kanker.

 
45 - Issaka RB (2014)

Issaka RB, Shapiro DM, Neehar DP et al. Palliative venting percutaneous endoscopic gastrostomy tube is safe and effective in patients with malignant obstruction. Surg Endosc 2014; 28: 1668-1673. [link]

 
46 - Kawata N (2014)

Kawata N, Kakushima N, Tanaka M, et al. Percutaneous endoscopic gastrostomy for decompression of malignant bowel obstruction. Dig Endosc 2014 26 : 208-213. [link]

 
47 - Kim YJ (2013)
Kim YJ, Yoon CJ, Seong NJ, et al. Safety and efficacy of radiological percutaneous jejunostomy for decompression of malignant small bowel obstruction. European Radiology 2013; 23: 2747-53. [link]
 
48 - Laval G (2014)
Laval G, Marcelin-Benazech B, Guirimand F, et al. Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manage 2014; 48(1): 75-91. [link]
 
49 - Laval G (2012)
Laval G, Rousselot H, Toussaint-Martel S, et al. SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction. Bull Cancer 2012; 99: E1-9. [link]
 
50 - Lee JH (2012)
Lee JH, Yoon JY, Park SJ et al. Thel learning curve for colorectal stent insertion for the treatment of malingnant colorectal obstruction. Gut Liver 2012; 6: 328-333. [link]
 
51 - Makary MA (2010)

Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010; 210(6): 901-8. [link]

 
52 - Mallo RD (2005)
Mallo RD, Salem L, Lalani T, et al. Computed tomography diagnosis of ischemia and complete obstruction in small bowel obstruction: a systematic review. J Gastro-intest Surg 2005; 9(5): 690-694. [link]
 
53 - Mangili G (2005)
Mangili G, Aletti G, Frigerio L, et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. International J Gynecol Cancer. 2005. 15: 830-35. [link]
 
54 - Mariani P (2012)
Mariani P, Blumberg J, Landau A, et al. Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 2012; 30: 4337-4343. [link]
 
55 - Mercadante S (2000)
Mercadante S, Ripamonti C, Casuccio A, et al. Comparison of octreotide and hyoscine butylbromide in controlling gastro-intestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 2000; 8: 188-191. [link]
 
56 - Mercadante S (1995)

Mercadante S. Bowel obstruction in home-care cancer patients: 4 years experience. Support Care Cancer 1995 3:190e3. [link]

 
57 - Naghibi M (2015)

Naghibi M, Smith TR, Elia M. A systematic review with meta-analysis of survival, quality of life and cost-effectiveness of home parenteral nutrition in patients with inoperabel malignant bowel obstruction, Clin Nutrition 2015; 34: 825-837. [link]

 
58 - Mercadante S (2015)
Mercadante S. Octreotide for malignant bowel obstruction: commentary on Currow et al. J Pain Symptom Manage 2015; 49: 813. [link]
 
59 - Merki HS (1993)

Merki HS, Halter F, Wilder-Smith CH. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine. Gastroenterology 1993 105: 748–54. [link]

 
60 - Mooney SJ (2013)

Mooney SJ, Winner M, Hershman DL, et al. Bowel obstruction in elderly ovarian cancer patients: a population-based study. Gynecol Oncol 2013; 129(1): 107-1. [link]

 
61 - Mystakidou K (2002)

Mystakidou K, Tsilika E, Kalaidopoulou O, et al. Comparison of octreotide administration versus conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial. Anticancer research 2002; 22: 1187-1192. [link]

 
62 - Ooijen van B (1993)
Ooijen van B, van der Burg ME, Planting AS, Siersema PD, Wiggers T.Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet 1993;176: 469-74. [link]
 
63 - Paul Olson TJ (2014)
Paul Olson TJ, Pinkerton C, Brasel KJ, et al. Palliative surgery for malignant bowel obstruction from carcinomatosis. JAMA Surgery 2014; 149: 383-92. [link]
 
64 - Peng X (2015)

Peng X, Wang P, Li S, et al. Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer. World J Surg Oncol 2015; 13: 50-56. [link]

 
65 - Pironi L (1997)
Pironi L, Ruggeri E, Tanneberger S, et al. Home artificial nutrition in advanced cancer. J R Soc Med1997;90:597e603. [link]
 
66 - Pol van de MHJ (2017)

Pol van de MHJ, Fluit C, Lagro J, et al. Shared decision making with frail older patients: Proposed teaching framework and practice recommendations. Gerontol Geriatr Educ. 2017 Oct-Dec;38(4):482-495. [link]

 
67 - Pothuri B (2005)

Pothuri B, Montemarano M, Gerardi M, et al. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol 2005; 96(2): 330-4. [link]

 
68 - Prichard PJ (1986)
Prichard PJ, Jones DB, Yeomans ND, et al. The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy. Br J Clin Pharmacol 1986; 22: 663-668. [link]
 
69 - Randen van A (2011)

Randen van A, Laméris W, Luitse JSK, et al. The role of plain radiographs in patients with acute abdominal pain at the ED. Am J Emerg Med 2011 11: 29(6): 582-589.e2. [link]

 
70 - Rath KS (2013)
Rath KS, Loseth D, Muscarella P et al. Outcomes following percutaneous upper gastro-intestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer. Gynecol Oncol 2013; 129: 103-106. [link]
 
71 - Ripamonti C (2008)
Ripamonti C, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008; 44(8): 1105-15. [link]
 
72 - Ripamonti C (2000)

Ripamonti C, Mercadante S, Groff L, et al. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 2000; 19: 23-34. [link]

 
73 - Ripamonti C (2001)

Ripamonti C, Twycross R, Baines M, et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage disease. Support Care Cancer. 2001; 9(4): 223-33. [link]

 
74 - Ryan JM (1998)

Ryan JM, Hahn PF, Mueller PR. Performing radiologic gastrostomy or gastrojejunostomy in patients with malignant ascites. Am J Roentgenol 1998;171:1003-6. [link]

 
75 - Sandvik AK (1997)
Sandvik AK, Brenna E, Waldum HL. Review article: the pharmacological inhibition of gastric acid secretion--tolerance and rebound. Aliment Pharmacol Ther 1997; 11: 1013-1018. [link]
 
76 - Shaw C (2013)

Shaw C, Bassett RL, Fox PS, et al. Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites. Ann Surg Oncol 2013; 20: 497-505. [link]

 
77 - Sugarbaker PH (2016)
Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastro-intestinal cancers with peritoneal metastases: Progress toward a new standerd of care. Cancer Treatment Rev 2016; 48: 42-9. [link]
 
78 - Suidan RS (2017)
Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, et al. Treatment patterns, outcomes, and costs for bowel obstruction in ovarian cancer. Int J Gynecol Cancer 2017; 27:1350-9. [link]
 
79 - Taylor MR (2013)
Taylor MR, Lalani N. Adult small bowel obstruction. Acad Emerg Med 2013; 20(6): 528-544. [link]
 
80 - Tseng WH (2011)

Tseng WH, Yang X, Wang H, et al. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg 2011: 254(2): 333-8. [link]

 
81 - Tuca A (2012)

Tuca A, Guell E, Martinez-Losada, Codorniu N. Malignant bowel obstruction in advanced cancer patients: epidemiology, management and factors, influencing spontaneous resolution. Cancer Manag Res 2012; 4:159-169. [link]

 
82 - Tuca A (2009)
Tuca A, Roca R, Sala C, et al. Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: a phase II clinical trial. J Pain Symptom Manage 2009; 37: 259-70. [link]
 
83 - VenVN (2011)
VenVN, Verpleegkundigen & Verzorgenden Nederland. Landelijke multidisciplinaire richtlijn neusmaagsonde, 2011. [link]
 
84 - Waldum HL (2014)

Waldum HL, Hauso Ø, Fossmark R. The regulation of gastric acid secretion - clinical perspectives. Acta Physiol 2014: 210: 239-256. [link]

 
85 - Walsh D (2016)
Walsh D, Mellar D, Ripamonti C, et al. 2016 updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer. Support Care Cancer 2017; 25: 333-340. [link]
 
86 - Weber C (2009)
Weber C, Zulian GB. Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics. Am J Hosp Palliat Care 2009; 26: 84-8. [link]
 
87 - Williams D (2011)
Williams D, Law R, Pullyblank AM. Colorectal stenting in malignant large bowel obstruction, the learning curve. Int J Surg Oncol 2011; 917848. doi: 10.1155/2011/917848. Epub 2010 Oct 11. [link]
 
88 - Xinopoulos D (2004)

Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysis. Surg Endosc 2004; 18: 421-6. 10.1007/s00464-003-8109-x. [link]

 
89 - Yang S (2016)
Yang S, Li S, Yu H, et al. Metronomic chemotherapy with 5-fluoro-uracil and cisplatin for inoperable malignant bowel obstruction because of peritoneal dissemination from gastric cancer. Current Oncol 2016; 23(3): e248-52. [link]
 
90 - Young CJ (2015)
Young CJ, De-Loyde KJ, Young JM, et al. Improving Quality of Life for People with Incurable Large-Bowel Obstruction: Randomized Control Trial of Colonic Stent Insertion. Dis colon Rectum 2015:838-49.10.1097/DCR.0000000000000431. [link]
 
91 - Zhao XD (2013)
Zhao XD, Cai BB, Cao RS, et al. Palliatieve treatment for incurable malignant colorec obstructions: a meta-analysis. World J Gastroenterology 2013; 19: 5565-5574. [link]
 
92 - Zucchi E (2016)

Zucchi E, Fornasarig M, Martella L et al. Decompressive percutaneous endoscopic gastrostomy in advance cancer patients with small-bowel obstruction is feasible and effective. Support Care Cancer 2016; 24: 2877-2882. [link]